Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery

NGAL as a Marker of Acute Kidney Injury After Cardiac Surgery. Observational Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01594788

Enrollment

340

Registered

2012-05-09

Start date

2011-04-30

Completion date

2012-12-31

Last updated

2012-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Brief summary

Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men or women over 18 years proposed for cardiac surgery with / without CPB. * Accepting to participate in the study, with informed consent signed by the patient, guardian or family member.

Exclusion criteria

* Patients \< 18 years. * Patients do not agree to participate in the study.

Countries

Spain

Contacts

Primary ContactMercedes Garcia, MD

mgarciaa@santpau.cat+34 93 553 75 41

Outcome results